Petro Borysko Bienta/Enamine Biography Publications Institution JoVE Articles Petro Borysko has not added a biography. If you are Petro Borysko and would like to personalize this page please email our Author Liaison for assistance. Publications Effect of Gem-Difluorination on the Key Physicochemical Properties Relevant to Medicinal Chemistry: The Case of Functionalized Cycloalkanes Chemistry (Weinheim an Der Bergstrasse, Germany). Apr, 2022 | Pubmed ID: 35147261 A Prospective Compound Screening Contest Identified Broader Inhibitors for Sirtuin 1 Scientific Reports. Dec, 2019 | Pubmed ID: 31863054 SAR by Space: Enriching Hit Sets from the Chemical Space Molecules (Basel, Switzerland). Aug, 2019 | Pubmed ID: 31454992 Pros and Cons of Virtual Screening Based on Public "Big Data": In Silico Mining for New Bromodomain Inhibitors European Journal of Medicinal Chemistry. Mar, 2019 | Pubmed ID: 30685526 (Chlorosulfonyl)benzenesulfonyl Fluorides-Versatile Building Blocks for Combinatorial Chemistry: Design, Synthesis and Evaluation of a Covalent Inhibitor Library ACS Combinatorial Science. Nov, 2018 | Pubmed ID: 30354064 Straightforward Hit Identification Approach in Fragment-based Discovery of Bromodomain-containing Protein 4 (BRD4) Inhibitors Bioorganic & Medicinal Chemistry. Jul, 2018 | Pubmed ID: 29764756 An Iterative Compound Screening Contest Method for Identifying Target Protein Inhibitors Using the Tyrosine-protein Kinase Yes Scientific Reports. Sep, 2017 | Pubmed ID: 28931921 Evaluación in vitro e in vivo de compuestos biológicamente activos fotocontrolados: posibles candidatos a fármacos para la fotofarmacología del cáncer Kateryna Horbatok*1,2, Tetyana Makhnii*2, Viktoriia Kosach2, Volodymyr Danko1, Andrey Kovalenko1, Stanislav Fatiushchenkov1, Petro Borysko2, Iryna Pishel2, Oleg Babii3,4, Anne S. Ulrich3, Tim Schober4, Sergii Afonin3, Igor V. Komarov1,2,4 1Taras Shevchenko National University of Kyiv, 2Bienta/Enamine, 3Karlsruhe Institute of Technology, 4Lumobiotics JoVE 64902 Chimie
Evaluación in vitro e in vivo de compuestos biológicamente activos fotocontrolados: posibles candidatos a fármacos para la fotofarmacología del cáncer Kateryna Horbatok*1,2, Tetyana Makhnii*2, Viktoriia Kosach2, Volodymyr Danko1, Andrey Kovalenko1, Stanislav Fatiushchenkov1, Petro Borysko2, Iryna Pishel2, Oleg Babii3,4, Anne S. Ulrich3, Tim Schober4, Sergii Afonin3, Igor V. Komarov1,2,4 1Taras Shevchenko National University of Kyiv, 2Bienta/Enamine, 3Karlsruhe Institute of Technology, 4Lumobiotics JoVE 64902 Chimie
